|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, Amortization And Non-Cash Lease Expense | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Total depreciation, Amortization And Non-Cash Lease Expense | |||||
| Provision for uncollectible accounts receivable | |||||
| Gain (Loss) on Disposition of Assets | |||||
| Deferred income taxes | |||||
| Share-based compensation | |||||
| Impairment of goodwill and intangible assets | |||||
| Loss on impairment of goodwill, intangible assets, and property, plant and equipment | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Income taxes payable | |||||
| Operating lease assets and liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of short-term investments | |||||
| Sales and maturities of short-term investments | |||||
| Capital expenditures | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from credit facilities | |||||
| Repayments of Lines of Credit | |||||
| Payment of line of credit issuance fees | |||||
| Proceeds from issuance of common stock related to share-based compensation | |||||
| Tax payments related to share-based compensation | |||||
| Repurchase of common stock | |||||
| Cash dividends paid | |||||
| Net cash used in financing activities | |||||
| Net effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the period for income taxes | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Property, plant and equipment acquired through increase in liabilities | |||||
Loading...